{"filing":{"accession_number":"0001077183-26-000037","cik":"0001077183","ticker":"NEO","company_name":"NEOGENOMICS INC","form":"8-K","filing_date":"2026-06-22","report_date":null,"primary_document":"neo-20260616.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718326000037/neo-20260616.htm"},"events":[{"id":12878,"run_id":11427,"accession_number":"0001077183-26-000037","anchor_item_number":"1.01","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"NeoGenomics completed the issuance of $316.25 million in aggregate principal amount of 0.75% Convertible Senior Notes due 2032 pursuant to an Indenture dated June 22, 2026, with up to 30,147,733 shares of common stock potentially issuable upon conversion at an initial conversion rate of 95.3288 shares per $1,000 principal. The offering was conducted as an unregistered private placement under Section 4(a)(2) and Rule 144A. The issuance represents a material creation of a direct financial obligation and a dilutive equity component, with concurrent debt repurchases and capped call terminations as ancillary refinancing mechanics.","company_name":"NEOGENOMICS INC","ticker":"NEO","filing_date":"2026-06-22","form":"8-K","submitted_at":null,"items":[{"id":9851,"accession_number":"0001077183-26-000037","item_number":"1.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"NeoGenomics completed the issuance of $316.25 million in aggregate principal amount of 0.75% Convertible Senior Notes due 2032 pursuant to an Indenture dated June 22, 2026. This is a material creation of a direct financial obligation—a convertible debt issuance—which is the core event disclosed under Item 1.01. The filing details the terms, conversion mechanics, redemption provisions, and related capped call hedging transactions, all hallmarks of a significant debt capital raise.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T21:35:12.584449+00:00","company_name":"","ticker":null,"filing_date":""},{"id":9852,"accession_number":"0001077183-26-000037","item_number":"2.03","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Item 2.03 is the standard location for debt issuance disclosures. The section incorporates Item 1.01 by reference, which typically covers material agreements including debt instruments. Without access to Item 1.01 itself, the reference structure strongly suggests a debt issuance or credit facility arrangement, making this the most probable event type for a 2.03 filing.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T21:35:12.584449+00:00","company_name":"","ticker":null,"filing_date":""},{"id":9853,"accession_number":"0001077183-26-000037","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"NeoGenomics sold convertible notes in an unregistered offering under Section 4(a)(2) and Rule 144A, with up to 30,147,733 shares of common stock potentially issuable upon conversion at an initial conversion rate of 95.3288 shares per $1,000 principal. This is a classic dilutive issuance—a private placement of convertible securities with substantial equity upside that would materially affect shareholder ownership and is disclosed under Item 3.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T21:35:12.584449+00:00","company_name":"","ticker":null,"filing_date":""},{"id":9854,"accession_number":"0001077183-26-000037","item_number":"8.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses concurrent debt issuance (the \"Notes\") and related capital transactions. While the section emphasizes note repurchases (~$276M principal) and capped call terminations, the triggering event is the pricing of new convertible notes, which creates a direct financial obligation. The repurchases and share buybacks are ancillary refinancing mechanics tied to the new issuance. This is material as it represents a significant capital restructuring affecting the company's debt and equity structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T21:35:12.584449+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9851,"accession_number":"0001077183-26-000037","item_number":"1.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"NeoGenomics completed the issuance of $316.25 million in aggregate principal amount of 0.75% Convertible Senior Notes due 2032 pursuant to an Indenture dated June 22, 2026. This is a material creation of a direct financial obligation—a convertible debt issuance—which is the core event disclosed under Item 1.01. The filing details the terms, conversion mechanics, redemption provisions, and related capped call hedging transactions, all hallmarks of a significant debt capital raise.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T21:35:12.584449+00:00","company_name":"NEOGENOMICS INC","ticker":"NEO","filing_date":"2026-06-22"},{"id":9852,"accession_number":"0001077183-26-000037","item_number":"2.03","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Item 2.03 is the standard location for debt issuance disclosures. The section incorporates Item 1.01 by reference, which typically covers material agreements including debt instruments. Without access to Item 1.01 itself, the reference structure strongly suggests a debt issuance or credit facility arrangement, making this the most probable event type for a 2.03 filing.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T21:35:12.584449+00:00","company_name":"NEOGENOMICS INC","ticker":"NEO","filing_date":"2026-06-22"},{"id":9853,"accession_number":"0001077183-26-000037","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"NeoGenomics sold convertible notes in an unregistered offering under Section 4(a)(2) and Rule 144A, with up to 30,147,733 shares of common stock potentially issuable upon conversion at an initial conversion rate of 95.3288 shares per $1,000 principal. This is a classic dilutive issuance—a private placement of convertible securities with substantial equity upside that would materially affect shareholder ownership and is disclosed under Item 3.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T21:35:12.584449+00:00","company_name":"NEOGENOMICS INC","ticker":"NEO","filing_date":"2026-06-22"},{"id":9854,"accession_number":"0001077183-26-000037","item_number":"8.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses concurrent debt issuance (the \"Notes\") and related capital transactions. While the section emphasizes note repurchases (~$276M principal) and capped call terminations, the triggering event is the pricing of new convertible notes, which creates a direct financial obligation. The repurchases and share buybacks are ancillary refinancing mechanics tied to the new issuance. This is material as it represents a significant capital restructuring affecting the company's debt and equity structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T21:35:12.584449+00:00","company_name":"NEOGENOMICS INC","ticker":"NEO","filing_date":"2026-06-22"}]}